Home/Pipeline/Portfolio across CNS, Oncology, Cardiology, etc.

Portfolio across CNS, Oncology, Cardiology, etc.

Various (See Therapeutic Areas)

Commercial / Generic DevelopmentActive

Key Facts

Indication
Various (See Therapeutic Areas)
Phase
Commercial / Generic Development
Status
Active
Company

About Abdi Ibrahim

Abdi İbrahim is a century-old, privately-held Turkish pharmaceutical powerhouse with a fully integrated business model spanning R&D, manufacturing, and commercialization. It maintains a diverse portfolio of branded generics and specialty medicines, supported by major production facilities in Turkey, Kazakhstan, and Algeria. The company is expanding its international footprint through subsidiaries and strategic partnerships, while investing in sustainability, talent development, and social innovation programs to secure future growth.

View full company profile